ELN
E559469
ELN was the stock ticker symbol for Elan Pharmaceuticals, an Irish biotechnology company known for developing treatments for neurological and autoimmune diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| ELN canonical | 1 |
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
analgesic drug
ⓘ
biotechnology company ⓘ monoclonal antibody drug ⓘ stock ticker symbol ⓘ |
| acquiredBy | Perrigo NERFINISHED ⓘ |
| acquisitionDate | 2013 ⓘ |
| associatedCompany | Elan Pharmaceuticals NERFINISHED ⓘ |
| collaboratedWith | Biogen Idec NERFINISHED ⓘ |
| country | Ireland NERFINISHED ⓘ |
| countryOfIncorporation | Ireland NERFINISHED ⓘ |
| developed |
Prialt
NERFINISHED
ⓘ
Tysabri NERFINISHED ⓘ |
| dissolved | 2013 ⓘ |
| field |
Autoimmune diseases
ⓘ
Neurology ⓘ |
| focus |
Alzheimer's disease research
ⓘ
neurodegenerative diseases ⓘ |
| foundedBy |
American Home Products (spin-out origin context)
NERFINISHED
ⓘ
Donal Geaney NERFINISHED ⓘ |
| headquartersLocation | Dublin, Ireland NERFINISHED ⓘ |
| industry |
Biotechnology
ⓘ
Pharmaceuticals ⓘ |
| listedOn |
Irish Stock Exchange
NERFINISHED
ⓘ
New York Stock Exchange ⓘ |
| notableDrug |
Prialt
NERFINISHED
ⓘ
Tysabri NERFINISHED ⓘ |
| notableTechnology | drug delivery technologies ⓘ |
| represents | Elan Pharmaceuticals NERFINISHED ⓘ |
| researchArea |
central nervous system disorders
ⓘ
immunology ⓘ |
| specializesIn |
treatments for autoimmune diseases
ⓘ
treatments for neurological diseases ⓘ |
| status | defunct as independent company ⓘ |
| stockExchange |
Irish Stock Exchange
NERFINISHED
ⓘ
New York Stock Exchange ⓘ |
| stockTicker | ELN NERFINISHED ⓘ |
| tradedAs | ELN NERFINISHED ⓘ |
| treats |
Crohn's disease
ⓘ
multiple sclerosis ⓘ severe chronic pain ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.